论文部分内容阅读
美国休斯顿安德森医院和肿瘤研究所的Michael Keating等根据一项前瞻性研究在国际急性白血病讨论会上称,患急性髓细胞性白血病病人的细胞遗传形式是对化疗有效与否的最明显的预后指征。细胞遗传形式在估计预后中似乎比以前认为的一些其它因素更为重要,包括病人的年龄、原发癌病史和血红蛋白水平。前瞻性研究包括1983～1985年在安德森医院治疗的 132名急性髓细胞性白血病病人。这项研究是对1973～1983年经各种化疗的800多
According to a prospective study at the International Symposium on Acute Leukemia, Michael Keating at the Anderson Hospital and Cancer Institute in Houston, said the most obvious prognosis of patients with acute myeloid leukemia, cytogenetic, is valid for chemotherapy Levy Cytogenetic patterns appear to be more important in estimating prognosis than some of the other factors previously thought, including patient age, primary cancer history, and hemoglobin levels. Prospective studies included 132 acute myeloid leukemia patients treated at Anderson Hospital from 1983 to 1985. This study was performed on more than 800 of various chemotherapies from 1973 to 1983